Deciphering radiopharmaceutical mechanisms through integrated proteomic and PTM-proteomic profiling

Area of Science:

• Proteomics and Molecular Biology
• Radiopharmaceutical Science
• Cancer Research

Background:

• Protein post-translational modifications (PTMs) are crucial for understanding disease pathways and drug responses.
• The regulatory mechanisms of radiopharmaceuticals on proteomic and PTM landscapes are not well understood.

Purpose of the Study:

• To investigate the integrated regulatory mechanisms of radiopharmaceuticals across proteomic and PTM landscapes.
• To provide a comprehensive proteomic and PTM-proteomic landscape of radiopharmaceutical regulation.

Main Methods:

• Quantitative multi-level proteomic analysis including glycoproteomics, phosphoproteomics, and global proteomics.
• Analysis of subcellular signaling pathways with site-specific PTMs in tumor tissues from radiopharmaceutical-treated mouse models.

Main Results:

• Identification of differentially expressed molecular signatures associated with radiopharmaceutical action.
• Uncovered multi-level cellular molecular mechanisms including DNA repair, extracellular matrix organization, and metabolic regulation.

Conclusions:

• This study elucidates the molecular mechanisms of radiopharmaceuticals at the proteomic and PTM-proteomic levels.
• Findings offer valuable insights for the development of novel radiopharmaceuticals.